STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Summit Partners discloses 12.03% beneficial ownership in Klaviyo

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Summit Partners-affiliated funds filed Amendment No. 5 to Schedule 13G reporting their beneficial ownership in Klaviyo, Inc. (KVYO). The group reports an aggregate 12.03% of Klaviyo’s Series A Common Stock, calculated based on 137,856,147 Series A shares outstanding as of October 31, 2025, plus 18,852,778 Series A shares issuable upon conversion of their Series B shares.

The reported securities are held across several entities, including Fund IX-A with 11,142,414 Series A shares issuable (7.11%) and Fund IX-B with 6,957,168 issuable (4.44%), alongside smaller positions by Kiwi Co-Invest, Fund IX/VC IV, and Fund IX/VC IV (UK). Voting and dispositive powers are reported as shared in amounts corresponding to each fund’s position. The filing notes that certain principals may be deemed to share authority, while all parties disclaim beneficial ownership beyond their direct holdings.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Represents 11,142,414 shares of Series A Common Stock ("Series A Shares") issuable in respect of 11,142,414 shares of Series B Common Stock ("Series B Shares"). Calculated based upon 137,856,147 Series A Shares outstanding as of October 31, 2025 as reported on the Issuer's Quarterly Report on Form 10-Q (the "10-Q") filed with the Securities and Exchange Commission ("SEC") on November 5, 2025, as increased by an aggregate of 18,852,778 Series A Shares issuable in respect of the 18,852,778 Series B Shares held by the Summit Holders (as defined in Item 2).


SCHEDULE 13G




Comment for Type of Reporting Person: Represents 6,957,168 Series A Shares issuable in respect of 6,957,168 Series B Shares. Calculated based upon 137,856,147 Series A Shares outstanding as of October 31, 2025 as reported on the Issuer's 10-Q filed with the SEC on November 5, 2025, as increased by an aggregate of 18,852,778 Series A Shares issuable in respect of the 18,852,778 Series B Shares held by the Summit Holders (as defined in Item 2).


SCHEDULE 13G




Comment for Type of Reporting Person: Represents 687,035 Series A Shares issuable in respect of 687,035 Series B Shares. Calculated based upon 137,856,147 Series A Shares outstanding as of October 31, 2025 as reported on the Issuer's 10-Q filed with the SEC on November 5, 2025, as increased by an aggregate of 18,852,778 Series A Shares issuable in respect of the 18,852,778 Series B Shares held by the Summit Holders (as defined in Item 2).


SCHEDULE 13G




Comment for Type of Reporting Person: Represents 58,561 Series A Shares issuable in respect of 58,561 Series B Shares. Calculated based upon 137,856,147 Series A Shares outstanding as of October 31, 2025 as reported on the Issuer's 10-Q filed with the SEC on November 5, 2025, as increased by an aggregate of 18,852,778 Series A Shares issuable in respect of the 18,852,778 Series B Shares held by the Summit Holders (as defined in Item 2).


SCHEDULE 13G




Comment for Type of Reporting Person: Represents 7,600 Series A Shares issuable in respect of 7,600 Series B Shares. Calculated based upon 137,856,147 Series A Shares outstanding as of October 31, 2025 as reported on the Issuer's 10-Q filed with the SEC on November 5, 2025, as increased by an aggregate of 18,852,778 Series A Shares issuable in respect of the 18,852,778 Series B Shares held by the Summit Holders (as defined in Item 2).


SCHEDULE 13G




Comment for Type of Reporting Person: Represents 18,852,778 Series A Shares issuable in respect of 18,852,778 Series B Shares. Calculated based upon 137,856,147 Series A Shares outstanding as of October 31, 2025 as reported on the Issuer's 10-Q filed with the SEC on November 5, 2025, as increased by an aggregate of 18,852,778 Series A Shares issuable in respect of the 18,852,778 Series B Shares held by the Summit Holders (as defined in Item 2).


SCHEDULE 13G



Summit Partners Growth Equity Fund IX-A, L.P.
Signature:/s/ Adam H. Hennessey, as POA
Name/Title:Adam H. Hennessey, as Power of Attorney
Date:11/13/2025
Summit Partners Growth Equity Fund IX-B, L.P.
Signature:/s/ Adam H. Hennessey, as POA
Name/Title:Adam H. Hennessey, as Power of Attorney
Date:11/13/2025
Summit Partners Co-Invest (Kiwi), L.P.
Signature:/s/ Adam H. Hennessey, as POA
Name/Title:Adam H. Hennessey, as Power of Attorney
Date:11/13/2025
Summit Investors GE IX/VC IV, LLC
Signature:/s/ Adam H. Hennessey, as POA
Name/Title:Adam H. Hennessey, as Power of Attorney
Date:11/13/2025
Summit Investors GE IX/VC IV (UK), L.P.
Signature:/s/ Adam H. Hennessey, as POA
Name/Title:Adam H. Hennessey, as Power of Attorney
Date:11/13/2025
Summit Partners, L.P.
Signature:/s/ Adam H. Hennessey, as POA
Name/Title:Adam H. Hennessey, as Power of Attorney
Date:11/13/2025

Comments accompanying signature: Exhibit A Joint Filing Agreement, dated as of January 31, 2024, incorporated by reference to the Schedule 13G filed by the Reporting Persons on January 31, 2024 Exhibit B Powers of Attorney, incorporated herein by reference to of the statement on Schedule 13G filed by the Reporting Persons on January 31, 2024

FAQ

What stake in Klaviyo (KVYO) do Summit Partners-affiliated funds report?

They report an aggregate 12.03% beneficial ownership of Klaviyo’s Series A Common Stock, based on shares outstanding as of October 31, 2025 plus shares issuable upon conversion.

How many shares underpin the Summit Partners group’s reported position in KVYO?

The position reflects 18,852,778 Series A shares issuable upon conversion of an equal number of Series B shares held by the reporting entities.

What are the largest individual fund positions disclosed for KVYO?

Fund IX-A: 11,142,414 Series A shares issuable (7.11%). Fund IX-B: 6,957,168 Series A shares issuable (4.44%).

What reference share count did the filing use for KVYO?

It uses 137,856,147 Series A shares outstanding as of October 31, 2025, as reported in Klaviyo’s Form 10‑Q filed on November 5, 2025.

Do the reporting persons have shared voting and dispositive power?

Yes. Each fund reports shared voting and shared dispositive power in amounts matching its respective shares issuable.

Which other affiliated vehicles hold KVYO shares in the filing?

Additional holders include Kiwi Co‑Invest (687,035), Fund IX/VC IV (58,561), and Fund IX/VC IV (UK) (7,600), each as Series A shares issuable.
Klaviyo, Inc.

NYSE:KVYO

KVYO Rankings

KVYO Latest News

KVYO Latest SEC Filings

KVYO Stock Data

8.50B
136.49M
0.39%
88.56%
2.24%
Software - Infrastructure
Services-prepackaged Software
Link
United States
BOSTON